UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 240

Sortiert nach

Differences in resting energy expenditure and body composition between patients with schizophrenia and healthy controls

Acta psychiatrica Scandinavica, 2006-07, Vol.114 (1), p.27-35

2006

Volltextzugriff (PDF)

Aberrant amino acid transport in fibroblasts from patients with bipolar disorder

Neuroscience letters, 2009, Vol.457 (1), p.49-52

2009

Volltextzugriff (PDF)

Physical capacity, respiratory quotient and energy expenditure during exercise in male patients with schizophrenia compared with healthy controls

European psychiatry, 2012-04, Vol.27 (3), p.206-212

2012

Volltextzugriff (PDF)

Niacin skin-flush response and electrodermal activity in patients with schizophrenia and healthy controls

Prostaglandins, leukotrienes and essential fatty acids, 2006-05, Vol.74 (5), p.339-346

2006

Volltextzugriff (PDF)

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients

Biological psychiatry (1969), 1993-02, Vol.33 (4), p.227-235

1993

Volltextzugriff (PDF)

Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controls

Psychiatry research, 1999-05, Vol.86 (2), p.113-129

1999

Volltextzugriff (PDF)

Needs assessed by psychiatric health care and social services in a defined cohort of clients with mental disabilities

European archives of psychiatry and clinical neuroscience, 2005-02, Vol.255 (1), p.57-64

2005

Volltextzugriff (PDF)

D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

Psychopharmacologia, 1989, Vol.99 Suppl (S1), p.S28-S31

1989

Volltextzugriff (PDF)

Muscle biopsy, macro EMG, and clinical characteristics in patients with schizophrenia

Biological psychiatry (1969), 2000-06, Vol.47 (11), p.991-999

2000

Volltextzugriff (PDF)

An open clinical and biochemical study of ritanserin in acute patients with schizophrenia

Psychopharmacologia, 1994-02, Vol.114 (1), p.31-38

1994

Volltextzugriff (PDF)

Characterization of dopamine receptor binding sites in the subthalamic nucleus

Neuroreport, 1994-09, Vol.5 (14), p.1836-1838

1994

Volltextzugriff (PDF)

An open label trial of raclopride in acute schizophrenia: confirmation of D2-dopamine receptor occupancy by PET

Psychopharmacologia, 1988-01, Vol.94 (1), p.1-7

1988

Volltextzugriff (PDF)

Chronic treatment with a classical neuroleptic alters excitatory amino acid and GABAergic neurotransmission in specific regions of the rat brain

Neuroscience, 1994-12, Vol.63 (4), p.1003-1020

1994

Volltextzugriff (PDF)

Tyrosine transport is regulated differently in patients with schizophrenia

Schizophrenia research, 1999-11, Vol.40 (1), p.37-42

1999

Volltextzugriff (PDF)

Functional characterization of tyrosine transport in fibroblast cells from healthy controls

Neuroscience letters, 2008, Vol.434 (1), p.56-60

2008

Volltextzugriff (PDF)

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

The Lancet (British edition), 2008-03, Vol.371 (9618), p.1085-1097

2008

Volltextzugriff (PDF)

Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers

Biological psychiatry (1969), 1988-04, Vol.23 (7), p.689-697

1988

Volltextzugriff (PDF)

Tyrosine transport as an indicator of cell membrane dysfunction in schizophrenia

Prostaglandins, leukotrienes and essential fatty acids, 1996-08, Vol.55 (1), p.55-58

1996

Volltextzugriff (PDF)

Tyrosine transport in schizophrenia

Schizophrenia research, 1994-10, Vol.13 (3), p.255-258

1994

Volltextzugriff (PDF)

Neurochemical changes in the entopeduncular nucleus and increased oral behavior in rats treated subchronically with clozapine or haloperidol

Synapse (New York, N.Y.), 1999-12, Vol.34 (3), p.192-207

1999

Volltextzugriff (PDF)

Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates

Acta psychiatrica Scandinavica, 1987-12, Vol.76 (6), p.628-641

1987

Volltextzugriff (PDF)

Decreased tyrosine transport in fibroblasts from schizophrenic patients

Life sciences (1973), 1987-12, Vol.41 (25), p.2749-2757

1987

Volltextzugriff (PDF)

Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment

Psychopharmacologia, 1989-01, Vol.99 (3), p.322-327

1989

Volltextzugriff (PDF)

Effects of sulpiride and chlorpromazine on regional cerebral glucose metabolism in schizophrenic patients as determined by positron emission tomography

Psychopharmacologia, 1989-03, Vol.97 (3), p.309-318

1989

Volltextzugriff (PDF)

Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis

Psychological medicine, 2013-12, Vol.43 (12), p.2571-2582

2013

Volltextzugriff (PDF)

1 – 25 von 240

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(211)
Mit Volltextzugriff
(169)

Publikationsform

Artikel
(240)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Humans
(200)
Science & Technology
(161)
Life Sciences & Biomedicine
(154)
Male
(134)
Female
(117)
Adult
(94)
Biological And Medical Sciences
(94)
Medical Sciences
(86)
Psychiatry
(58)
Middle Aged
(52)
Animals
(49)
Neurosciences & Neurology
(44)
Psychology. Psychoanalysis. Psychiatry
(42)
Neurosciences
(38)
Schizophrenia
(38)
Tomography, Emission-Computed
(34)
Rats
(33)
Pharmacology. Drug Treatments
(31)
Schizophrenia - Drug Therapy
(30)
Adolescent
(29)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Differences in resting energy expenditure and body composition between patients with schizophrenia and healthy controls

Aberrant amino acid transport in fibroblasts from patients with bipolar disorder

Physical capacity, respiratory quotient and energy expenditure during exercise in male patients with schizophrenia compared with healthy controls

Niacin skin-flush response and electrodermal activity in patients with schizophrenia and healthy controls

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients

Neurological signs and psychomotor performance in patients with schizophrenia, their relatives and healthy controls

Needs assessed by psychiatric health care and social services in a defined cohort of clients with mental disabilities

D1- and D2-dopamine receptor occupancy during treatment with conventional and atypical neuroleptics

Muscle biopsy, macro EMG, and clinical characteristics in patients with schizophrenia

An open clinical and biochemical study of ritanserin in acute patients with schizophrenia

Characterization of dopamine receptor binding sites in the subthalamic nucleus

An open label trial of raclopride in acute schizophrenia: confirmation of D2-dopamine receptor occupancy by PET

Chronic treatment with a classical neuroleptic alters excitatory amino acid and GABAergic neurotransmission in specific regions of the rat brain

Tyrosine transport is regulated differently in patients with schizophrenia

Functional characterization of tyrosine transport in fibroblast cells from healthy controls

Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial

Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers

Tyrosine transport as an indicator of cell membrane dysfunction in schizophrenia

Tyrosine transport in schizophrenia

Neurochemical changes in the entopeduncular nucleus and increased oral behavior in rats treated subchronically with clozapine or haloperidol

Regional brain glucose metabolism in drug free schizophrenic patients and clinical correlates

Decreased tyrosine transport in fibroblasts from schizophrenic patients

Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment

Effects of sulpiride and chlorpromazine on regional cerebral glucose metabolism in schizophrenic patients as determined by positron emission tomography

Hyperprolactinemia in antipsychotic-naive patients with first-episode psychosis

Aktive Filter

Suchergebnisse filtern